Cureab ^Companies

Cureab is a Swiss biotech company established in 2012, specializing in inflammation and oncology research. They develop therapeutic antibodies from target identification to clinical testing, with two monoclonal antibodies currently in late-stage pre-clinical development. Cureab is open to forming partnerships with academic and industrial entities.